Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?

被引：0

作者：

Goupille, Philippe ^{[1
]}

Wendling, Daniel ^{[2
]}

机构：

[1] Univ Tours, Trousseau Hosp, Rheumatol Dept, CHU Tours,EA 6295, Ave Republ, F-37044 Tours 9, France

[2] Univ Franche Comte, Rheumatol Dept, CHU Besancon, EA 4266, Besancon, France

来源：

JOINT BONE SPINE | 2024年 / 91卷 / 03期

关键词：

Axial spondyloarthritis; Treatment; C-reactive protein; CLINICAL-RESPONSE; DOUBLE-BLIND; ADALIMUMAB; PREDICTORS; EFFICACY; THERAPY; SAFETY;

D O I：

10.1016/j.jbspin.2023.105662

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 29 条

[11] Ixekizumab Is Effective in the Treatment of Radiographic Axial Spondyloarthritis Regardless of the Level of C-Reactive Protein or Magnetic Resonance Imaging Scores
Maksymowych, Walter P.
Gallo, Gaia
Bolce, Rebecca
Zhao, Fangyi
Geneus, Vladimir
Ostergaard, Mikkel
Tada, Kurisu
Deodhar, Atul
Gensler, Lianne
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[12] Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials
Roche, Damien
Badard, Martin
Boyer, Laurent
Lafforgue, Pierre
Thao Pham
ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
[13] Induction Treatment with Anti-TNF Decreases C-Reactive Protein Levels among Crohn's Disease Patients: A Systematic Review and Meta-analysis
Kuenzig, Ellen
Vallerand, Isabelle
Rezaie, Ali
Panaccione, Remo
Seow, Cynthia
Leung, Yvette
Heitman, Steven
Ghosh, Subrata
Kaplan, Gilaad
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S540 - S540
[14] Changing patterns of Anti-TNF medication use in 9074 rheumatoid arthritis patients between 2000-2005: Shorter treatment duration and quicker switching between Anti-TNF agents, with less than 50% of patients still on initial Anti-TNF medication at 2 years.
Yazici, Yusuf
Barnes, Jaime P.
Hines, Patricia L.
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S350 - S350
[15] Baseline C-reactive protein (CRP) and plasma anti-TNF concentration in patients with active Crohn's disease treated with certolizumab pegol
Sandborn, William J.
Feagan, Brian G.
Lee, Scott
Binion, David G.
Loftus, Edward V.
Pierre-Louis, Bosny
Ullman, Thomas A.
INFLAMMATORY BOWEL DISEASES, 2011, 17 : S20 - S21
[16] Systematic Literature Review and Network Meta-Analysis Comparing Incidence of Uveitis and IBD in Axial Spondyloarthritis Patients Treated with Anti-TNF versus Anti-IL17A in Placebo Controlled Randomized Trials
Roche, Damien
Badard, Martin
Boyer, Laurent
Lafforgue, Pierre
Pham, Thao
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[17] Baseline C-reactive Protein (CRP) and Plasma Anti-TNF Concentration in Patients with Active Crohn's Disease Treated with certolizumab pegol (CZP)
Sandborn, William
Feagan, Brian
Lee, Scott
Binion, David
Loftus, Edward
Pierre-Louis, Bosny
Ullman, Thomas
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S454 - S454
[18] C-reactive protein lowers the serum level of IL-17, but not TNF-α, and decreases the incidence of collagen-induced arthritis in mice
Singh, Sanjay K.
Prislovsky, Amanda
Ngwa, Donald N.
Munkhsaikhan, Undral
Abidi, Ammaar H.
Brand, David D.
Agrawal, Alok
FRONTIERS IN IMMUNOLOGY, 2024, 15
[19] SERUM ALBUMIN AND C-REACTIVE PROTEIN WEEK 2/WEEK 0 RATIO AFTER ANTI-TNF THERAPY BEST PREDICT BOTH SHORT- AND LONG-TERM CLINICAL OUTCOMES IN ANTI-TNF NAIVE ULCERATIVE COLITIS PATIENTS
Lee, Sun-Ho
Kim, Min-Ju
Chang, Kiju
Song, Eun Mi
Hwang, Sung Wook
Park, Sang Hyoung
Yang, Dong-Hoon
Byeon, Jeong-Sik
Myung, Seung-Jae
Yang, Suk-Kyun
Ye, Byong Duk
GASTROENTEROLOGY, 2018, 154 (06) : S187 - S188
[20] ANTI-IL-6 AUTOANTIBODY INHIBITED ELEVATION OF SERUM C-REACTIVE PROTEIN LEVEL IN TWO PATIENTS WITH SEVERE BACTERIAL INFECTION
Nanki, T.
Onoue, I.
Nagasaka, K.
Hirata, S.
Hosoya, T.
Ebisawa, M.
Sugihara, T.
Harigai, M.
Miyasaka, N.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 314 - 314

← 1 2 3 →